-
HPQ
-
$27.70
-
-1.32%
-
$28.07
-
$28.25
-
$27.57
Prices as of 2025-10-29 16:20:40 ET
Ticker Appearances
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
Daily Technical Strategy
Tech remains quite strong vs. SPX despite some mixed results
QQQ, DJIA AND SPX ARE RIGHT AT OCTOBER LOWS, AND SHOULD ATTEMPT TO MAKE A STAND THIS WEEK. HOWEVER, THIS LIKELY DOES DEPEND ON STELLAR...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
First Word
COVID-19 UPDATE: USA on cusp of "40%" level that presaged 53% plunge in Israel cases... Updating Granny Shots, +9, -13, net -4 stocks = 28 grREVISED Granny Shot ideas
So 3 of the major items over the weekend were all positive and support the US moving towards a full re-opening by mid-June. Of these...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
Daily Technical Strategy
Tech remains quite strong vs. SPX despite some mixed results
QQQ, DJIA AND SPX ARE RIGHT AT OCTOBER LOWS, AND SHOULD ATTEMPT TO MAKE A STAND THIS WEEK. HOWEVER, THIS LIKELY DOES DEPEND ON STELLAR...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
First Word
COVID-19 UPDATE: USA on cusp of "40%" level that presaged 53% plunge in Israel cases... Updating Granny Shots, +9, -13, net -4 stocks = 28 grREVISED Granny Shot ideas
So 3 of the major items over the weekend were all positive and support the US moving towards a full re-opening by mid-June. Of these...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 8db2d8-5fe288-02f723-f44484-cca7af
Visitor: 8db2d8-5fe288-02f723-f44484-cca7af Array ( [cookie] => 8db2d8-5fe288-02f723-f44484-cca7af [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.105 )
